Co-delivery of drugs and plasmid DNA for cancer therapy
PY Teo, W Cheng, JL Hedrick, YY Yang - Advanced drug delivery reviews, 2016 - Elsevier
Cancer is an extremely complex disease involving multiple signaling pathways that enable
tumor cells to evade programmed cell death, thus making cancer treatment extremely …
tumor cells to evade programmed cell death, thus making cancer treatment extremely …
Nanomedicines for the treatment of hematological malignancies
AK Deshantri, AV Moreira, V Ecker… - Journal of controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …
[HTML][HTML] A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy
Designing a transformable nanosystem with improved tumor accumulation and penetration
by tuning multiple physicochemical properties remains a challenge. Here, a near-infrared …
by tuning multiple physicochemical properties remains a challenge. Here, a near-infrared …
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
J Liu, M Li, Z Luo, L Dai, X Guo, K Cai - Nano Today, 2017 - Elsevier
Nanoscale drug delivery systems (NDDS) have shown great potential in tumor treatment
due to its unique advantages, especially its unique enhanced permeability and retention …
due to its unique advantages, especially its unique enhanced permeability and retention …
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Background Neuroblastoma (NB) represents the most frequent and aggressive form of
extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and partially …
extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and partially …
Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: in vitro and in vivo anti-tumor study
Liposomal formulations were made using Solvent-assisted active loading technology
(SALT). Two formulations composed of HSPC: DPPG: Chol: DSPE-mPEG 2000 (PG …
(SALT). Two formulations composed of HSPC: DPPG: Chol: DSPE-mPEG 2000 (PG …
Progress on the application of bortezomib and bortezomib-based nanoformulations
J Liu, R Zhao, X Jiang, Z Li, B Zhang - Biomolecules, 2021 - mdpi.com
Bortezomib (BTZ) is the first proteasome inhibitor approved by the Food and Drug
Administration. It can bind to the amino acid residues of the 26S proteasome, thereby …
Administration. It can bind to the amino acid residues of the 26S proteasome, thereby …
Assembly of catechol-modified polymer brushes for drug delivery
Therapeutic nanoparticles (NPs) have shown their potential for biomedical applications (eg,
drug delivery). In this study, we report the synthesis of a bottlebrush block copolymer by ring …
drug delivery). In this study, we report the synthesis of a bottlebrush block copolymer by ring …
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
Mitochondria serve as both “energy factories” and “suicide weapon stores” of cells. Targeted
delivery of cytotoxic drugs to the mitochondria of tumor cells and tumor vascular cells is a …
delivery of cytotoxic drugs to the mitochondria of tumor cells and tumor vascular cells is a …
Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy
Nanocarriers (NCs) are a group of nano-sized vehicles devised to deliver drugs to targeted
malignant tissues or organs that provide remarkably improved targeting efficiency and …
malignant tissues or organs that provide remarkably improved targeting efficiency and …